NCT00905047 2026-03-13
COLOCROSS
Centre Oscar Lambret
Phase 3 Completed
Clinical Trials
2,239 trialsNCT02310477 2026-03-13
REBECCA
Centre Oscar Lambret
Completed
NCT06654622 2026-03-13
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
City of Hope Medical Center
Completed
NCT01904955 2026-03-12
Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort
Centre Hospitalier Universitaire Dijon
Completed
NCT03223779 2026-03-12
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Massachusetts General Hospital
Phase 1/2 Completed
NCT03239145 2026-03-12
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00102011 2026-03-09
00-046
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT05162846 2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT04705818 2026-03-06
CAIRE
Institut Bergonié
Phase 2 Completed
NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT03519412 2026-03-03
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2 Completed
NCT06866678 2026-03-03
Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Completed
NCT07180303 2026-03-03
CRC-RPHC
The First Affiliated Hospital with Nanjing Medical University
Phase NA Completed
NCT06137170 2026-03-02
RegoSeq
Bayer
Completed
NCT03510858 2026-02-27
Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians
University of Bern
Phase NA Completed
NCT03640208 2026-02-27
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans
Case Comprehensive Cancer Center
Phase NA Completed
NCT03828799 2026-02-27
FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
NCT04761185 2026-02-25
Raltitrexed in HIPEC
Fudan University
Phase 1 Completed
NCT01105169 2026-02-20
Precision-Based Magnesium Trial
Vanderbilt University Medical Center
Phase NA Completed
NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
NCT06994832 2026-02-18
Using Visual Arrays to Support Understanding of Genetic Risk
Massachusetts General Hospital
Phase NA Completed
NCT07413510 2026-02-17
Precision Nursing vs Conventional Care in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial
Jiangsu Cancer Institute & Hospital
Phase NA Completed
NCT05116085 2026-02-13
Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer
BeOne Medicines
Phase 2 Completed
NCT05702684 2026-02-12
Personalised Cancer Care and Support: Identifying What Good Looks Like
King's College London
Completed
NCT06475664 2026-02-12
Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial
University of Minnesota
Phase EARLY_PHASE1 Completed
NCT03362177 2026-02-11
RECITE
Amgen
Phase 3 Completed
NCT05383976 2026-02-11
PCSNaP
Abramson Cancer Center at Penn Medicine
Completed
NCT05036109 2026-02-10
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
Phase NA Completed
NCT05648240 2026-02-10
EARDIS
Centre Hospitalier Universitaire de Nīmes
Completed
NCT07391163 2026-02-10
Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer
Tanta University
Phase NA Completed
NCT07398820 2026-02-10
IMPACT OF SEDENTARY BEHAVIOR IN THE HOMEOSTASIS OF THE DIGESTIVE ECOSYSTEM
Clínica Universidad de los Andes
Completed
NCT07401004 2026-02-10
Blink
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT03712943 2026-02-09
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02956876 2026-02-06
INCISIVE
University Hospital, Rouen
Phase 3 Completed
NCT04513223 2026-02-06
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT05520840 2026-02-06
COLODIAG
University Hospital, Rouen
Phase NA Completed
NCT05536713 2026-02-06
U-Screen
Milton S. Hershey Medical Center
Completed
NCT00208260 2026-02-05
Intensified Chemotherapy in CRC After Resection of Liver Metastases
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2/3 Completed
NCT00556413 2026-02-05
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT00989469 2026-02-05
NEXIRI
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
NCT04776148 2026-02-05
MK-7902-017
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03707574 2026-02-04
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Completed
NCT06379880 2026-02-04
FEGALA
Centre Paul Strauss
Phase NA Completed
NCT05102500 2026-02-03
Second Opinions in Oncology
University of Colorado, Denver
Completed
NCT04414306 2026-02-02
Screen to Save 2: Rural Cancer Screening Educational Intervention
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT05064410 2026-02-02
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT05731947 2026-01-29
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
Syndax Pharmaceuticals
Phase 1/2 Completed
NCT04362839 2026-01-28
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
City of Hope Medical Center
Phase 1 Completed
NCT03798626 2026-01-27
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Novartis
Phase 1 Completed
NCT04640480 2026-01-27
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
SN BioScience
Phase 1 Completed